Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Cicalini

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|September 18, 2012
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfectionLiliana Elena Weimer, Vincenzo Fragola, Marco Floridia, et al.
BMC Infectious Diseases|April 14, 2023
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimensPaolo Maggi, Elena Delfina Ricci, Stefania Cicalini, et al.
Journal of Clinical Medicine|March 25, 2022
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWHRoberta Gagliardini, Alessandra Vergori, Patrizia Lorenzini, et al.
International Journal of Antimicrobial Agents|December 6, 2023
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)Marta Camici, Roberta Gagliardini, Simone Lanini, et al.
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte CountAndrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Sexually Transmitted Infections|May 12, 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in ItalyLavinia Fabeni, Claudia Alteri, Giulia Berno, et al.
Eclinicalmedicine|March 20, 2023
Sarilumab plus standard of care <i>vs</i> standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, et al.
Pharmacological Research|August 30, 2023
Pillars of long-term antiretroviral therapy successLucia Taramasso, Massimo Andreoni, Andrea Antinori, et al.
Scientific Reports|October 22, 2025
Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME projectMarianna Meschiari, Francesco Vladimiro Segala, Altea Gallerani, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|September 18, 2012
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfectionLiliana Elena Weimer, Vincenzo Fragola, Marco Floridia, et al.
BMC Infectious Diseases|April 14, 2023
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimensPaolo Maggi, Elena Delfina Ricci, Stefania Cicalini, et al.
Journal of Clinical Medicine|March 25, 2022
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWHRoberta Gagliardini, Alessandra Vergori, Patrizia Lorenzini, et al.
International Journal of Antimicrobial Agents|December 6, 2023
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)Marta Camici, Roberta Gagliardini, Simone Lanini, et al.
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte CountAndrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Sexually Transmitted Infections|May 12, 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in ItalyLavinia Fabeni, Claudia Alteri, Giulia Berno, et al.
Eclinicalmedicine|March 20, 2023
Sarilumab plus standard of care <i>vs</i> standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, et al.
Pharmacological Research|August 30, 2023
Pillars of long-term antiretroviral therapy successLucia Taramasso, Massimo Andreoni, Andrea Antinori, et al.
Scientific Reports|October 22, 2025
Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME projectMarianna Meschiari, Francesco Vladimiro Segala, Altea Gallerani, et al.
Pageof 9